American Oncology Network, Inc. is a microcap healthcare stock trading on the OTCQX, with rising revenue but lagging net income and earnings due to share issuances and one-time costs. I maintain a Buy rating for bold investors, emphasizing the company's growth potential despite current profitability challenges and limited information. The company has shown significant revenue growth and expansion in provider numbers and locations, indicating strong market positioning and future growth prospects.